These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 15125308)
1. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death]. Kecskeméti V Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308 [TBL] [Abstract][Full Text] [Related]
2. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes. Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686 [TBL] [Abstract][Full Text] [Related]
3. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval]. Calderone V; Cavero I Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149 [TBL] [Abstract][Full Text] [Related]
5. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group]. Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V; Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs. Vieweg WV J Clin Psychiatry; 2002; 63 Suppl 9():18-24. PubMed ID: 12088172 [TBL] [Abstract][Full Text] [Related]
8. Long QT syndrome caused by noncardiac drugs. Viskin S; Justo D; Halkin A; Zeltser D Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598 [TBL] [Abstract][Full Text] [Related]
9. [Antipsychotic drugs and cardiovascular safety: current studies of prolonged QT interval and risk of ventricular arrhythmia]. Gury C; Canceil O; Iaria P Encephale; 2000; 26(6):62-72. PubMed ID: 11217540 [TBL] [Abstract][Full Text] [Related]
10. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Haddad PM; Anderson IM Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926 [TBL] [Abstract][Full Text] [Related]
12. Drug-induced QT prolongation and proarrhythmia: an inevitable link? Ahmad K; Dorian P Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320 [TBL] [Abstract][Full Text] [Related]
14. QT interval prolongation, torsade de pointes and renal disease. Patanè S; Marte F; Di Bella G; Currò A; Coglitore S Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic medications and cardiac conduction risks. Roman M; Farmer SY Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166 [No Abstract] [Full Text] [Related]
16. Drugs, QT interval abnormalities and ventricular arrhythmias. Thomas SH Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900 [No Abstract] [Full Text] [Related]
17. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817 [TBL] [Abstract][Full Text] [Related]
18. Role of potassium currents in cardiac arrhythmias. Ravens U; Cerbai E Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotic-induced sudden cardiac death: examination of an atypical reaction. Killeen MJ Expert Opin Drug Saf; 2009 May; 8(3):249-52. PubMed ID: 19505259 [TBL] [Abstract][Full Text] [Related]